α-TerthiopheneCAS# 1081-34-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1081-34-1 | SDF | Download SDF |
PubChem ID | 65067 | Appearance | Light yellow crystalline powder |
Formula | C12H8S3 | M.Wt | 248.39 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2,5-dithiophen-2-ylthiophene | ||
SMILES | C1=CSC(=C1)C2=CC=C(S2)C3=CC=CS3 | ||
Standard InChIKey | KXSFECAJUBPPFE-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H8S3/c1-3-9(13-7-1)11-5-6-12(15-11)10-4-2-8-14-10/h1-8H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
α-Terthiophene Dilution Calculator
α-Terthiophene Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.0259 mL | 20.1296 mL | 40.2593 mL | 80.5185 mL | 100.6482 mL |
5 mM | 0.8052 mL | 4.0259 mL | 8.0519 mL | 16.1037 mL | 20.1296 mL |
10 mM | 0.4026 mL | 2.013 mL | 4.0259 mL | 8.0519 mL | 10.0648 mL |
50 mM | 0.0805 mL | 0.4026 mL | 0.8052 mL | 1.6104 mL | 2.013 mL |
100 mM | 0.0403 mL | 0.2013 mL | 0.4026 mL | 0.8052 mL | 1.0065 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- KT 5720
Catalog No.:BCC8080
CAS No.:108068-98-0
- CP-466722
Catalog No.:BCC3912
CAS No.:1080622-86-1
- Roxindole hydrochloride
Catalog No.:BCC7116
CAS No.:108050-82-4
- Tilmicosin
Catalog No.:BCC4865
CAS No.:108050-54-0
- Ambocin
Catalog No.:BCN7748
CAS No.:108044-05-9
- Bergenin monohydrate
Catalog No.:BCC8132
CAS No.:108032-11-7
- (-)-Noe's Reagent
Catalog No.:BCC8375
CAS No.:108031-79-4
- Withanolide C
Catalog No.:BCN6729
CAS No.:108030-78-0
- H-Tyr-Ome
Catalog No.:BCC3126
CAS No.:1080-06-4
- Phenol
Catalog No.:BCN3800
CAS No.:108-95-2
- Melamine
Catalog No.:BCN7248
CAS No.:108-78-1
- 6-Methyl-5,6-dihydropyran-2-one
Catalog No.:BCN3498
CAS No.:108-54-3
- 6-(beta-D-glucopyranosyloxy)-Salicylic acid methyl ester
Catalog No.:BCN1631
CAS No.:108124-75-0
- SKF 83566 hydrobromide
Catalog No.:BCC7121
CAS No.:108179-91-5
- TUG 424
Catalog No.:BCC7776
CAS No.:1082058-99-8
- TC-S 7005
Catalog No.:BCC6189
CAS No.:1082739-92-1
- PDE-9 inhibitor
Catalog No.:BCC1842
CAS No.:1082743-70-1
- PF-04447943
Catalog No.:BCC1850
CAS No.:1082744-20-4
- LY2584702
Catalog No.:BCC6369
CAS No.:1082949-67-4
- A 987306
Catalog No.:BCC7732
CAS No.:1082954-71-9
- Cariprazine hydrochloride
Catalog No.:BCC1454
CAS No.:1083076-69-0
- 1,7-Bis(4-hydroxyphenyl)hept-6-en-3-ol
Catalog No.:BCN1630
CAS No.:1083195-05-4
- 1,7-Bis(4-hydroxyphenyl)hept-1-en-3-one
Catalog No.:BCN1629
CAS No.:1083200-79-6
- Fmoc-D-Asn-OH
Catalog No.:BCC3083
CAS No.:108321-39-7
Thiotagetin B and tagetannins A and B, new acetylenic thiophene and digalloyl glucose derivatives from Tagetes minuta and evaluation of their in vitro antioxidative and anti-inflammatory activity.[Pubmed:29288025]
Fitoterapia. 2018 Mar;125:78-88.
The three new metabolites: thiotagetin B (2) [(Z)-1''-([2,2'-bithiophen]-5-yl)-8''-chloro-6'',11''-dimethylundeca-6'',10''-die n-2''-yn-9''-one], tagetannin A (9) [3,4-bis-(galloyl-3,5-dimethyl ether)-(alpha/beta)-d-glucopyranose], and tagetannin B (10) [2,3-bis-(galloyl-3,5-dimethyl ether)-(alpha/beta)-d-glucopyranose], along with ecliptal (5-formyl-alpha-terthiophene) (1), 5-(4-hydroxybut-1-ynyl)-2,2'-bithiophene (3), scopoletin (4), p-hydroxybenzoic acid (5), protocatechuic acid methyl ester (6), gallic acid (7), and patuletin 7-O-beta-d-glucoside (8) were isolated from the aerial parts of Tagetes minuta L. (Asteraceae). Their structures were verified by extensive spectroscopic analyses as well as by comparison with literature data. The isolated compounds were evaluated for their antioxidant and anti-inflammatory activities using DPPH and enzyme-linked immunosorbent assays, respectively. Compounds 5-10 possessed the highest antioxidant potential with a scavenging activity (SCA) approximately 74 to 93% of DPPH radicals. Moreover, 5-10 displayed significant anti-inflammatory potential, while 4 showed moderate activity. Compounds 5-10 exhibited significant decreases in NFkappaB p65, TNF-alpha, and IL-6 levels at all tested concentrations.
Gateway state-mediated, long-range tunnelling in molecular wires.[Pubmed:29376529]
Nanoscale. 2018 Feb 8;10(6):3060-3067.
If the factors controlling the decay in single-molecule electrical conductance G with molecular length L could be understood and controlled, then this would be a significant step forward in the design of high-conductance molecular wires. For a wide variety of molecules conducting by phase coherent tunnelling, conductance G decays with length following the relationship G = Ae(-betaL). It is widely accepted that the attenuation coefficient beta is determined by the position of the Fermi energy of the electrodes relative to the energy of frontier orbitals of the molecular bridge, whereas the terminal anchor groups which bind to the molecule to the electrodes contribute to the pre-exponential factor A. We examine this premise for several series of molecules which contain a central conjugated moiety (phenyl, viologen or alpha-terthiophene) connected on either side to alkane chains of varying length, with each end terminated by thiol or thiomethyl anchor groups. In contrast with this expectation, we demonstrate both experimentally and theoretically that additional electronic states located on thiol anchor groups can significantly decrease the value of beta, by giving rise to resonances close to EF through coupling to the bridge moiety. This interplay between the gateway states and their coupling to a central conjugated moiety in the molecular bridges creates a new design strategy for realising higher-transmission molecular wires by taking advantage of the electrode-molecule interface properties.